| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.3M | — | +4.9% |
| Cost of Revenue | $5.2M | — | +25.5% |
| Gross Profit | $19.0M | — | +0.4% |
| R&D Expense | $664K | — | +4.7% |
| SG&A Expense | $3.8M | — | -11.5% |
| Operating Income | $3.4M | — | -9.4% |
| Pre-tax Income | $3.4M | — | -22.4% |
| Income Tax | $942K | — | -19.7% |
| Net Income | $2.5M | — | -21.8% |
| EPS (Basic) | $0.23 | — | -14.8% |
| EPS (Diluted) | $0.23 | — | -11.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.6M | +5.6% | -7.9% |
| Accounts Receivable | $13.5M | +26.2% | +9.3% |
| Current Assets | $28.4M | +21.5% | +8.0% |
| Total Assets | $50.9M | +12.6% | +3.4% |
| Current Liabilities | $39.2M | +14.7% | +7.1% |
| Total Liabilities | $54.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.9M | — | +17.3% |
| Capital Expenditures | $8K | — | -61.9% |
| Investing Cash Flow | -$8K | — | +61.9% |
| Financing Cash Flow | -$3.3M | — | +63.4% |
| Free Cash Flow | $3.8M | — | +17.8% |
| +7.3% |
| Stockholders' Equity | -$8.3M | -10.0% | -36.6% |